REGN•benzinga•
$1000 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth This Much
Summary
Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years by 12.55% on an annualized basis producing an average annual return of 19.7%. Currently, Regeneron Pharmaceuticals has a market capitalization of $72.59 billion.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 4, 2022 by benzinga